Aptamer Sciences, Inc. was founded in April 2011 by world-class experts in the field of aptamer technology with the vision of “Global No.1 Biotech Company”.

The company is an R&D based bio venture company focused on commercializing cutting-edge Aptamer Technology Platforms for the development of innovative therapeutic and diagnostic products.

We offer high quality aptamers with superior binding affinity and specificity. Our aptamer-based platforms include the generation of high-quality aptamers, aptamer optimization, and development of new therapeutic and diagnostic techniques.